SureTrader Advertisement Advertisement Advertisement
Home > Boards > US OTC > Medical - Drugs >

Cellceutix Corporation (CTIX)

Add CTIX Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator BigKahuna, TheDane, BooDog, KarinCA, noretreat, TOB
Search This Board:
Last Post: 11/28/2015 9:44:58 AM - Followers: 678 - Board type: Free - Posts Today: 8

Cellceutix Corporation (CTIX)
Company Address:
100 Cumming Center, Suite 151-B
Beverly, MA 01915
Phone: 978-236-8717
Fax:  978-921-6564
CIK:  0001355250
Cellceutix is a publicly traded company under the symbol “CTIX”. Cellceutix is a clinical stage biopharmaceutical company developing innovative therapies in oncology, dermatology and antibiotic applications. Cellceutix believes it has a world-class portfolio of compounds and is now engaged in advancing its compounds and seeking strategic partnerships. Cellceutix’s anti-cancer drug Kevetrin is currently in a Phase 1 clinical trial at Harvard Cancer Centers’ Dana Farber Cancer Institute and Beth Israel Deaconess Medical Center. In the laboratory Kevetrin has shown to induce activation of p53, often referred to as the “Guardian Angel Gene” due to its crucial role in controlling cell mutations. Cellceutix is planning a Phase 2 clinical trial with its novel compound Brilacidin-OM for the prevention and treatment of Oral Mucositis. Brilacidin-OM, a defensin mimetic compound, has shown in the laboratory to reduce the occurrence of severe ulcerative oral mucositis by more than 94% compared to placebo. Cellceutix’s anti-psoriasis drug Prurisol is presently in a bioequivalence crossover clinical trial in Miami, FL. Prurisol is a small molecule that acts through immune modulation and PRINS reduction. Cellceutix’s key antibiotic, Brilacidin, is in a Phase 2b trial for Acute Bacterial Skin and Skin Structure Infections, or ABSSSI. Brilacidin has the potential to be a single-dose therapy or a dosing regimen that is shorter than currently marketed antibiotics for multi-drug resistant bacteria (Superbugs). Cellceutix has formed research collaborations with world-renowned research institutions in the United States and Europe, including MD Anderson Cancer Center, Beth Israel Deaconess Medical Center, and the University of Bologna.


The above link is kept updated.

Ongoing Human Trials:
Product Pipeline:


Recent News and Press Releases:

Seeking Alpha focus articles on CTIX:

A randomized, double-blind study comparing single-dose and short-course brilacidin to daptomycin in the treatment of acute bacterial skin & skin structure infections (ABSSSI)

Synthetic novel host defense protein mimetics for the treatment of Gram-negative bacterial infections

SEC Filings:

Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f

Share Structure:  See SEC filing link above for current share structure

Cellceutix IP - Patent Filings:

Publication number US8338454 B2
Publication type Grant
Application number US 12/780,132
Publication date Dec 25, 2012
Filing date May 14, 2010
Priority date May 20, 2009
Also published as CA2762427A1, CN102438612A, EP2432464A2, US20100298374, US20130245062, WO2010135170A2, WO2010135170A3, Less «6 More »
Publication number 12780132, 780132, US 8338454 B2, US 8338454B2, US-B2-8338454, US8338454 B2, US8338454B2
Inventors Krishna Menon
Original Assignee Cellceutix Corporation
Export Citation BiBTeX, EndNote, RefMan
Patent Citations (6), Non-Patent Citations (41), Referenced by (1), Classifications (42)
External Links: USPTO, USPTO Assignment, Espacenet

Investor Relations:

Following is a WEEKLY chart:


All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock.  Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement:

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
CTIX News: Quarterly Report (10-q) 11/09/2015 04:13:18 PM
CTIX News: Current Report Filing (8-k) 11/03/2015 05:26:56 PM
CTIX News: Additional Proxy Soliciting Materials (definitive) (defa14a) 11/02/2015 06:07:08 AM
CTIX News: Proxy Statement (definitive) (def 14a) 10/28/2015 05:26:05 PM
CTIX News: Special Profile Coming and 4 Analyst Reports 07/21/2015 07:00:00 AM
#131275  Sticky Note FDA Grants Fast Track Designation to Cellceutix's Brilacidin-OM BigKahuna 11/25/15 12:53:52 PM
#131266  Sticky Note 11-25-15 $CTIX ~ Cellceutix Corp. Due Diligence Report TheHound 11/25/15 11:47:13 AM
#130877  Sticky Note $CTIX - Cellceutix Conducts Research on Retinoblastoma Cancer KarinCA 11/23/15 09:00:52 AM
#121761  Sticky Note Cellceutix Announces Filing of its Annual Report on TOB 09/14/15 09:28:06 AM
#117003  Sticky Note Cellceutix released efficacy data for Kevetrin, its cancer TOB 08/09/15 03:05:24 PM
#131469   Sounds fishy....Maybe Karin can get a message to Smooth 11/28/15 09:44:58 AM
#131468   Those shorting CTIX would like those who own AlanC 11/28/15 09:19:52 AM
#131467   SANCTIONS UNDER RULE 11 tome of background info on slcimmuno 11/28/15 09:09:10 AM
#131466   Good. loanranger 11/28/15 08:31:23 AM
#131465   YEP ! And using " Spiritual " messages wild4ctix 11/28/15 08:09:25 AM
#131464   "Motions take 2-4 weeks to get a written decision." loanranger 11/28/15 08:02:29 AM
#131463   I believe I understood your message from the Detonate 11/28/15 04:46:56 AM
#131462   Agree Dane...esp. since the investor in question claimed Justfactsmam 11/28/15 03:08:10 AM
#131461   Short Sale Volume Reporting’s are deceiving. Rdunn88 11/27/15 11:41:57 PM
#131460   Not the whole thing,... Just this next step cabel 11/27/15 09:41:00 PM
#131459   cabel-this will take at least 6 months +..imo JTORENCE 11/27/15 09:12:06 PM
#131458   Thank you for posting. Excellent response I think. scottsmith 11/27/15 08:46:58 PM
#131457   Somehow I think I did a lousy job loanranger 11/27/15 08:31:29 PM
#131456   When do we expect the judge to rule,...? cabel 11/27/15 08:04:02 PM
#131455   Great suggestion. Thanks! Detonate 11/27/15 07:48:05 PM
#131454   Neither of ours copied properly. Yet, a KarinCA 11/27/15 07:40:29 PM
#131453   Rosen made quite a few mistakes. It KarinCA 11/27/15 07:34:14 PM
#131452   Who told their friends and family, or enemies Cassius Longinus 11/27/15 07:34:06 PM
#131451   We have lingered a few days in several noretreat 11/27/15 07:14:05 PM
#131450   Soon they will all resurface before the 2.00 Matagordaville 11/27/15 05:59:43 PM
#131449   I think he should wait a while longer TheDane 11/27/15 05:49:29 PM
#131448   FINRA short sales of CTIX AlanC 11/27/15 05:48:57 PM
#131447   Thanks Loanranger grizzlyman 11/27/15 05:47:40 PM
#131446   Thinking about it. There was a gap down etradeedge 11/27/15 05:44:12 PM
#131445   Thanks for the link (please see ps). Sometimes loanranger 11/27/15 05:35:10 PM
#131444   FINRA reports show there have been no significant TheHound 11/27/15 05:34:02 PM
#131443   Posting the announcement so soon by Rosen was F1ash 11/27/15 05:25:26 PM
#131442   Sullivan response to plaintiff's reply on 11.24.15 KarinCA 11/27/15 05:12:59 PM
#131441   Mothership........ Welcome back Double E? Or still on Matagordaville 11/27/15 05:11:53 PM
#131440   They only lost if they sold (cowards), got Phteven C 11/27/15 04:39:02 PM
#131439   Shkreli targeted HIV positive toxoplasmosis sufferers just because sunspotter 11/27/15 04:32:48 PM
#131438   The capacity is limitless in that what is AlanC 11/27/15 04:31:43 PM
#131437   What about the scum that write inaccurate hit believer20 11/27/15 04:16:13 PM
#131436   There is only so much capacity for naked Phteven C 11/27/15 03:59:46 PM
#131435   The 1 million short reported by FINRA is AlanC 11/27/15 03:37:46 PM
#131434   Alan, There won't be a KaloBios type squeeze here. Phteven C 11/27/15 03:26:47 PM
#131433   If CTIX crushes the shorts will you say AlanC 11/27/15 03:15:14 PM
#131432   Shkreli is scum, pure and simple. By their friends sunspotter 11/27/15 03:05:13 PM
#131429   It's starting to look that way madam green is good 11/27/15 02:30:01 PM
#131428   $1.80 was great compared to $1 the first Phteven C 11/27/15 01:35:08 PM
#131425   When everyone least expects it $$$ CTIX tombrady12nh 11/27/15 01:13:08 PM
#131424   Slow and steady suppression in progress. ..standard CTIX Vlady 1 11/27/15 01:09:35 PM
#131423   It's different this time Bobby. Untold riches just Phteven C 11/27/15 01:09:03 PM
#131422   Is there anything that the SEC can do quaerere 11/27/15 12:49:50 PM
#131421   Just the facts: KMBJN 11/27/15 12:27:08 PM
#131420   ...Cleveland?...University of Cleveland Medical Center...perhaps Leo should alert Justfactsmam 11/27/15 12:10:52 PM
#131418   I agree with you in principle but am noretreat 11/27/15 11:57:27 AM
#131417   fairly soon anyway, and that run will not Waverunner1 11/27/15 11:45:56 AM
#131416   I think we'll have more time to accumulate...but noretreat 11/27/15 11:44:24 AM
#131415   FDA Grants Fast Track Designation to Cellceutix's Brilacidin-OM TheHound 11/27/15 11:40:37 AM